Other than that, oleocanthal treatment on mammary cancer cells and human hepatocellular carcinoma suppressed mesenchymal marker, vimentin, and N-cadherin and stabilized ZO-1 and E-cadherin expression suggested that oleocanthal was able to modulate EMT mechanisms [21,73]. The gene discussed is CDH1; the disease is hepatocellular carcinoma.